申请人:Gilead Sciences, Inc.
公开号:US20160250215A1
公开(公告)日:2016-09-01
Described herein are compounds of Formula (I) and tautomers and pharmaceutical salts thereof, compositions and formulations containing such compounds, and methods of using and making such compounds.
本文描述了式(I)的化合物及其互变异构体和药物盐,含有这种化合物的组合物和配方,以及使用和制备这种化合物的方法。